Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.

× No keyword cloud information.

15 in total

Review 1. Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.

Authors: Mayumi Nakagawa; William Greenfield; Andrea Moerman-Herzog; Hannah N Coleman
Journal: Clin Vaccine Immunol Date: 2015-05-06

Review 2. Topical treatments for cutaneous warts.

Authors: Chun Shing Kwok; Sam Gibbs; Cathy Bennett; Richard Holland; Rachel Abbott
Journal: Cochrane Database Syst Rev Date: 2012-09-12

3. A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine.

Authors: Shawna L Stratton; Horace J Spencer; William W Greenfield; Gordon Low; Wilbur C Hitt; Charles M Quick; Susanne K Jeffus; Victoria Blackmon; Mayumi Nakagawa
Journal: Clin Trials Date: 2015-01-09 Impact factor: 2.486

4. A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.

Authors: William W Greenfield; Shawna L Stratton; Rebecca S Myrick; Rita Vaughn; Lisa M Donnalley; Hannah N Coleman; Maria Mercado; Andrea M Moerman-Herzog; Horace J Spencer; Nancy R Andrews-Collins; Wilbur C Hitt; Gordon M Low; Nirvana A Manning; Samantha S McKelvey; Dora Smith; Michael V Smith; Amy M Phillips; C Matthew Quick; Susanne K Jeffus; Laura F Hutchins; Mayumi Nakagawa
Journal: Oncoimmunology Date: 2015-05-27 Impact factor: 8.110

5. Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.

Authors: Xingxuan Wang; Yuxin Che; Bingnan Chen; Yao Zhang; Mayumi Nakagawa; Xuelian Wang
Journal: Int Immunopharmacol Date: 2018-02-03 Impact factor: 4.932

6. IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.

Authors: Mayumi Nakagawa; Hannah N Coleman; Xuelian Wang; Jaclyn Daniels; James Sikes; Uma M Nagarajan
Journal: Cytokine Date: 2013-12-02 Impact factor: 3.861

Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts.

Review 1. Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines.

Review 2. Topical treatments for cutaneous warts.

3. A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine.

4. A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.

5. Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.

6. IL-12 secretion by Langerhans cells stimulated with Candida skin test reagent is mediated by dectin-1 in some healthy individuals.

7. Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

8. Psoriasis Exacerbation after Candida Antigen Immunotherapy Injection.

Review 9. Immunomodulators in warts: Unexplored or ineffective?

Review 10. Evolving role of immunotherapy in the treatment of refractory warts.